| Identification | Back Directory | [Name]
tert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate | [CAS]
1454848-24-8 | [Synonyms]
EOS-60599
tert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate
TERT-BUTYL N-[(4-BROMO-5-CYANO-1-METHYL-1H-PYRAZOL-3-YL)METHYL]-N-METHYLCARBAMATE
Carbamic acid, N-[(4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl]-N-methyl-, 1,1-dimethylethyl ester | [Molecular Formula]
C12H17BrN4O2 | [MDL Number]
MFCD30803236 | [MOL File]
1454848-24-8.mol | [Molecular Weight]
329.19 |
| Chemical Properties | Back Directory | [Boiling point ]
441.1±45.0 °C(Predicted) | [density ]
1.38±0.1 g/cm3(Predicted) | [pka]
-1.77±0.70(Predicted) | [InChI]
InChI=1S/C12H17BrN4O2/c1-12(2,3)19-11(18)16(4)7-8-10(13)9(6-14)17(5)15-8/h7H2,1-5H3 | [InChIKey]
XXLRKGVZBYVBNQ-UHFFFAOYSA-N | [SMILES]
C(OC(C)(C)C)(=O)N(CC1C(Br)=C(C#N)N(C)N=1)C |
| Hazard Information | Back Directory | [Uses]
tert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate is a pharmaceutical intermediate compound that can be used in the synthetic anticancer prescription drug Lorlatinib. Lorlatinib is a drug used in the treatment of non-small cell lung cancer caused by adult non-small cell lung cancer (NSCLC) caused by an unusual mesenchymal lymphoma. |
|
|